Group 1 - Beijing Rural Commercial Bank's Economic and Technological Development Zone Branch issued its first "Technology R&D Loan" of over 2.36 million yuan to Beijing Huanuo Tai Biopharmaceutical Technology Co., Ltd., providing crucial funding for vaccine innovation and R&D [1] - The loan will specifically support key aspects of vaccine R&D, including raw material procurement, laboratory equipment upgrades, and team support, addressing the financing challenges faced by biopharmaceutical companies due to a lack of collateral [1][2] - The innovative financing model transforms the company's R&D investment, core patents, and team qualifications into credit assessment criteria, allowing for more flexible financing solutions for technology-driven enterprises lacking tangible assets [2] Group 2 - The "Technology R&D Loan" is part of a broader financial service system aimed at supporting technology innovation, with Beijing Rural Commercial Bank offering a product matrix of 75 financial products covering the entire lifecycle of enterprises [3] - This initiative reflects the bank's commitment to addressing the financing difficulties of biopharmaceutical companies and supporting the real economy and technological innovation [3] - The bank plans to deepen its technological financial innovation practices and enhance its credit product offerings, contributing to the construction of an international technology innovation center in Beijing and the high-quality development of the real economy [3]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈之內容概不負責，對其準確性或完整 性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部分內容而產生或因倚賴該等內容而 引致之任何損失承擔任何責任。 於二零二六年二月四日，聯交所發出信函通知本公司，本公司股份 (「該股份」) 之最 後上市日期為二零二六年二月十三日 (「最後上市日期」) ，而該股份的上市地位將於 二零二六年二月十六日上午九時起取消。 GREATER BAY AREA DYNAMIC GROWTH HOLDING LIMITED 大灣區聚變力量控股有限公司 ((於百慕達註冊成立之有限公司) (股份代號: 1189) 上市覆核委員會的決定 取消上市地位 ; 公司秘書及授權代表辭任 本公佈乃由大灣區聚變力量控股有限公司（「本公司」，連同其附屬公司統稱「本集 團」）根據香港聯合交易所有限公司（「聯交所」）證券上市規則第 13.09 條及香港法例 第 571 章證券及期貨條例第 XIVA 部之內幕消息條文作出。 茲提述本公司於 2024 年 3 月 21 日、2024 年 4 月 2 日、2025 年 5 月 13 日、2025 年 5 月 1 ...

Group 1 - The company, Greater Bay Area Fusion Power (01189.HK), announced that its listing status will be canceled according to Listing Rule 6.01A(1) [1] - The cancellation of the listing status will take effect from February 16, 2026, at 9:00 AM [1]

Group 1 - The core announcement is that the listing status of Greater Bay Area Fusion Power Holdings Limited will be canceled by the Hong Kong Stock Exchange starting from 9:00 AM on February 16, 2026 [1]

Group 1 - The core announcement is that the listing status of Greater Bay Area Fusion Power Holdings Limited will be canceled by the Hong Kong Stock Exchange effective from February 16, 2026, at 9:00 AM [1] Group 2 - The cancellation of the listing status is based on the Listing Rules, specifically Article 6.01A(1) [1]

關於 大灣區聚變力量控股有限公司 （於百慕達註冊成立之有限公司） （股份代號：1189） 取消上市地位 香港聯合交易所有限公司 (香港交易及結算所有限公司全資附屬公司) THE STOCK EXCHANGE OF HONG KONG LIMITED (A wholly-owned subsidiary of Hong Kong Exchanges and Clearing Limited) 通告 香港聯合交易所有限公司（聯交所）宣布，由 2026 年 2 月 16 日上午 9 時起，大灣區聚變 力量控股有限公司（該公司）的上市地位將根據《上市規則》第 6.01A(1)條予以取消。 聯交所宣布，由 2026 年 2 月 16 日上午 9 時起，該公司的上市地位將根據《上市規則》第 6.01A(1)條予以取消。 該公司的股份自 2024 年 4 月 2 日起已暫停買賣。根據《上市規則》第 6.01A(1)條，若該公 司未能於 2025 年 10 月 1 日或之前復牌，聯交所可將該公司除牌。 於 2025 年 10 月 27 日，該公司向上市覆核委員會申請覆核上市委員會的決定。於 2026 年 2月3日，上市覆核委 ...

Group 1 - The chairman and executive director of the company, Tan Songshen, will suspend his duties starting from December 4, 2025 [1] - Executive director Wen Yuanyi has resigned from her position to allocate more time for personal matters, effective from December 4, 2025 [1] - Tan Jinjie has been appointed as the executive director and co-chairman of the board, effective from December 4, 2025 [1] Group 2 - Gao Xiong has been appointed as an independent non-executive director and a member of the audit committee, effective from December 4, 2025 [1] - Chen Rongzhuo has been appointed as a member of the nomination committee, effective from December 4, 2025 [1]

Group 1 - The company announced that Chairman and Executive Director Tan Songshen will suspend his duties starting December 4, 2025 [1] - Executive Director Wen Yuanyi has resigned from her position effective December 4, 2025, to allocate more time for personal matters [1] - Tan Jinjie has been appointed as Executive Director and Co-Chairman of the Board, effective December 4, 2025 [1] Group 2 - Gao Xiong has been appointed as an Independent Non-Executive Director and a member of the Audit Committee, effective December 4, 2025 [1] - Chen Rongzhuo has been appointed as a member of the Nomination Committee, effective December 4, 2025 [1]

Group 1 - The chairman and executive director of the company, Tan Songshen, has submitted his resignation due to health reasons, effective from December 4, 2025 [1] - The board has decided to retain Tan Songshen in a temporary capacity on sick leave until he is fit to resume his duties, during which he will continue to receive his director's remuneration [1] - Executive director Wen Yuanyi has also resigned to focus on personal matters, effective from December 4, 2025 [1] Group 2 - Tan Junjie has been appointed as the executive director and co-chairman of the board, effective from December 4, 2025 [1]

香港交易及結算所有限公司及香港聯合交易所有限公司對本公佈的內容概不負責，對 其準確性或完整性亦不發表任何聲明，並明確表示，概不對因本公佈全部或任何部分 內容而產生或因倚賴該等內容而引致的任何損失承擔任何責任。 GREATER BAY AREA DYNAMIC GROWTH HOLDING LIMITED 大灣區聚變力量控股有限公司 ( 於百慕達註冊成立之有限公司) （股份代號：1189） (1) 董事之變更； (2) 變更提名委員會成員； (3)不符合上市規則第 3.10A 條；及 (4)繼續暫停買賣 大灣區聚變力量控股有限公司（「本公司」，連同其附屬公司統稱「本集團」）的董事會 （「董事會」）及董事（「董事」）宣佈以下之董事變動： 董事會主席暫停職務 譚頌燊先生「譚主席」由於身體健康理由，日前向董事會提出辭任董事會主席及執行 董事職位。鑒於譚主席於在任期間對本集團作出之貢獻，董事會決議向譚主席提出挽 留，並以病假形式暫時停止職務，直至其身體狀況適合從新執行主席職務，而他在病 假期間仍有權獲得規定的董事袍金，譚主席已同意此項安排。據此，董事會宣佈譚主 席之董事會主席及執行董事職務自 2025 年 12 月 4 ...